Cell CellPress Article Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients'B Cells Yunlong Cao,1.10 Bin Su,2.10 Xianghua Guo,2.10 Wenjie Sun,1.10 Yongqiang Deng,3.10 Linlin Bao,.10 Qinyu Zhu,5.6.10 Xu Zhang,7 Yinghui Zheng,1 Chenyang Geng,1 Xiaoran Chai,1 Runsheng He,1 Xiaofeng Li,3 Qi Lv,4 Hua Zhu,4 Wei Deng, Yanfeng Xu,4 Yanjun Wang,2 Luxin Qiao,2 Yafang Tan,3 Liyang Song,1.5 Guopeng Wang,5 Xiaoxia Du,1.5 Ning Gao,6.8 Jiangning Liu,4 Junyu Xiao,5.6 Xiao-dong Su,1.5 Zongmin Du,3 Yingmei Feng,2 Chuan Qin,4.*Chengfeng Qin,3. Ronghua Jin,2.*and X.Sunney Xie1.6.9.11. ed Innovation Center for Genomics(ICG)&Biomedical Pioneering Innovation Center(BIOPIC),Peking Universit. 通过恢复期患者B细胞的高通量单细胞测序鉴定出针对 SARS-CoV-2的强效中和抗体
通过恢复期患者 B 细胞的高通量单细胞测序鉴定出针对 SARS-CoV-2 的强效中和抗体
如何获得针对新冠病毒的记忆性B细胞 1.样本来源 来自新冠康复病人的外周血单个核细胞 (PMBCs) #1#2#3 PBMCs isolation
如何获得针对新冠病毒的记忆性B细胞 来自新冠康复病人的外周血单个核细胞 （PMBCs) 1.样本来源